1993
DOI: 10.1016/0735-1097(93)90553-d
|View full text |Cite
|
Sign up to set email alerts
|

Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography

Abstract: This study demonstrates a heterogeneous pattern of neuronal abnormalities in patients with diabetic cardiac neuropathy. The extent of this abnormality correlated with the severity of neuropathy assessed by conventional tests. Future studies in larger groups of patients are required to define the relative sensitivity of this imaging approach in detecting cardiac neuropathy and to determine the clinical significance of these scintigraphic findings in comparison with conventional markers of autonomic innervation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
57
0
8

Year Published

1997
1997
2020
2020

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 113 publications
(68 citation statements)
references
References 11 publications
3
57
0
8
Order By: Relevance
“…Assessment of the heart by PET with 11C-HED in Type I diabetes confirms the frequent sympathetic dysinnervation and the predominance in the posterior myocardial region [79]. Complicating the heterogeneous cardiac sympathetic dysinnervation, with PET diabetic patients have been shown to have proximal sympathetic hyperinnervation of the heart [52].…”
Section: Scintigraphically Assessed Cardiac Sympathetic Dysfunctionmentioning
confidence: 99%
See 1 more Smart Citation
“…Assessment of the heart by PET with 11C-HED in Type I diabetes confirms the frequent sympathetic dysinnervation and the predominance in the posterior myocardial region [79]. Complicating the heterogeneous cardiac sympathetic dysinnervation, with PET diabetic patients have been shown to have proximal sympathetic hyperinnervation of the heart [52].…”
Section: Scintigraphically Assessed Cardiac Sympathetic Dysfunctionmentioning
confidence: 99%
“…Unlike noradreanline, MIBG and HED are metabolized neither by monoaminooxidase nor by catecholamine-O-methyltransferase [64,75,77]. They are rapidly excreted in the urine in their unmetabolized form [75,79,82].…”
Section: Scintigraphically Assessed Cardiac Sympathetic Dysfunctionmentioning
confidence: 99%
“…The distribution of myocardial sympathetic nerves can be assessed by dual-isotope imaging with radiolabelled metaiodobenzylguanidine, a norepinephrine analogue, or with radiolabelled catecholamines visualized by positron emission tomography [74,75]. Theoretically, these techniques should add valuable information to the heart-rate based testing of autonomic function, although they cannot distinguish between afferent and efferent nerve endings.…”
Section: Sympathetic Innervation Of the Heart And Lack Of Cardiac Painmentioning
confidence: 99%
“…Although the use of these tests has given rise to criticism and many noninvasive tests have appeared to assess the autonomic nervous function, they are expensive, they were not used in large populations and their sensitivities have not been established. If today we decide to perform an epidemiological study which includes the determination of the cardiovascular autonomic function in diabetic subjects at least one of the tests proposed by Ewing and Clarke must be done, complemented or not with alternative mathematical approaches for measuring heart rate variation (5,6), images with metaiodobenzylguanidine (7) or images obtained with positron emission tomography (8).…”
Section: Introductionmentioning
confidence: 99%